Opposition 91209377
OtherUSPTO
Opposition 91209377 at USPTO between Intel Corporation and Watson Pharmaceuticals, Inc., over the mark INTELLOGICS, filed Feb 19, 2013. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Feb 19, 2013
- Marks involved
- 34
Parties
Who is involved
The parties as named in the office record.
Timeline
How the case has moved
Dates from the USPTO record and the INTELLOGICS filing.
INTELLOGICS filed
Application 85545573 filed at the USPTO.Opposition filed
Intel Corporation started opposition 91209377 at USPTO against INTELLOGICS.
Marks
Marks involved
3 contested marks, 31 marks the challenger relies on.
| Mark | Role | Application | Office |
|---|---|---|---|
| INTELLOGICS | Contested | 85545573 | USPTO |
| INTELLOGICS - INSPIRED SOLUTIONS | Contested | 85545669 | USPTO |
| INTELLOGICS INSPIRED SOLUTIONS | Contested | 85550936 | USPTO |
| INTEL | Relied on | 72325488 | USPTO |
| INTEL | Relied on | 72384319 | USPTO |
| INTEL | Relied on | 72384320 | USPTO |
| INTEL | Relied on | 73035122 | USPTO |
| INTEL INSIDE | Relied on | 74159673 | USPTO |
| INTEL | Relied on | 74225506 | USPTO |
| INTEL | Relied on | 74225623 | USPTO |
| INTEL INSIDE | Relied on | 75160103 | USPTO |
| INTEL | Relied on | 75160105 | USPTO |
+22 more marks in this case
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_582a780d-85de-4d7b-834d-a32f34c8deaa
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_582a780d-85de-4d7b-834d-a32f34c8deaa",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91209377",
"status": "other",
"office_code": "US",
"filed_date": "2013-02-19",
"parties": [
{
"name": "Intel Corporation",
"role": "opponent"
},
{
"name": "Watson Pharmaceuticals, Inc.",
"role": "respondent"
}
]
}